[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346627-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346627-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","qu-shi-jie-du-decoction-for-prevention-of-recurrence-and-metastasis-in-high-risk-stage-iiiii-colon-cancer-study-protocol-for-a-double-blind-randomized-placebo-controlled-trial","Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer - Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial","","Colorectal cancer remains one of the most common and lethal malignancies globally, and stage II–III colon cancer patients frequently face recurrence and liver metastasis despite standard therapy, resulting in weakened disease-free survival and long-term outcomes. This protocol evaluates Qu-Shi-Jie-Du decoction (QSJDD), a traditional Chinese herbal formula, as an adjunctive approach to prevent tumor spread. The study uses a multicentre double-blind randomized placebo-controlled design with safety monitoring, clinical endpoints, and analyses including TCM dampness scoring and microbiome assessment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/qu-shi-jie-du-decoction-for-prevention-of-recurrence-and-metastasis-in-high-risk-stage-iiiii-colon-cancer-study-protocol-for-a-double-blind-randomized-placebo-controlled-trial/346627/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/qu-shi-jie-du-decoction-for-prevention-of-recurrence-and-metastasis-in-high-risk-stage-iiiii-colon-cancer-study-protocol-for-a-double-blind-randomized-placebo-controlled-trial/346627.png","ImageObject",300,407,{"name":42,"@type":43},"Ava Thompson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of this QSJDD clinical trial protocol?","Question",{"text":63,"@type":64},"To evaluate the safety and efficacy of Qu-Shi-Jie-Du decoction in preventing colon cancer recurrence and liver metastasis in high-risk stage II or III patients.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is the trial designed and what interventions will participants receive?",{"text":68,"@type":64},"This multicentre, double-blind, randomized, placebo-controlled trial assigns 336 patients to receive either QSJDD compound granules or placebo for 6 months after surgery and chemotherapy, followed for 3 years.",{"name":70,"@type":61,"acceptedAnswer":71},"What outcomes will be used to judge effectiveness and safety?",{"text":72,"@type":64},"The primary endpoint is the 3-year disease-free survival rate, with secondary endpoints including 1- and 2-year disease-free survival, overall survival, and changes in the Traditional Chinese Medicine Dampness Syndrome Scale, while safety and adverse events will be tracked.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346627,1790147240,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer: Study Protocol for a Double-Blind, Randomized, PlaceboControlled Trial  \nIntegrative Cancer Therapies Volume 25: 1–14 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15347354251396002](DOI: 10.1177/15347354251396002)[ ](DOI: 10.1177/15347354251396002)[journals.sagepub.com/home/ict](journals.sagepub.com/home/ict)  \nYa-dong Chen 1,2,3*, Zi-yan He 1,2*, Wen-jie Zhao 1,2,3, Yi-han He 1,2,3, Yi-hong Liu 1,2, Yan-juan Zhu 1,2,3, Ya-ya Yu 1,2,3, Zhen-zhen Xiao 1,2,3, Xue-song Chang 1,2,3, Zong-bin Liu4, and Hai-bo Zhang, PhD 1,2,3,5,6,7  \nAbstract  \nBackground: Colorectal cancer is one of the most common and fatal cancers worldwide. Despite therapeutic advancements, patients with stage II and III colon cancer often experience recurrences and metastases, particularly to the liver, leading to suboptimal disease-free survival (DFS) rates and decreased long-term survival. Qu-Shi-Jie-Du decoction (QSJDD), a traditional Chinese herbal formula, may prevent cancer recurrence and spread by boosting immunity, reducing inflammation, and inhibiting tumour growth. Preliminary studies have demonstrated that QSJDD reduces liver metastasis in patients with colon cancer. However, robust clinical evidence is required to confirm its efficacy and safety.  \nObjective: This study aims to evaluate the safety and efficacy of QSJDD in preventing colon cancer recurrence and liver metastasis, thereby offering a potential adjunctive therapy to improve patient outcomes.  \nMethods: This multicentre, double-blind, randomised, placebo-controlled trial involves 336 high-risk stage II or III colon cancer patients from 10 Chinese hospitals. Post-surgery and chemotherapy, 168 patients will receive either QSJDD compound granules or a placebo for 6 months, with a 3-year follow-up and evaluations every 6 months. The primary endpoint is to measure the 3-year DFS rate, while secondary endpoints include 1 -and 2-year DFS rates, overall survival, and changes in the Traditional Chinese Medicine Dampness Syndrome Scale. Safety and adverse events will be tracked, and blood and gut microbiomes will be analysed to assess QSJDD’s impact on delaying colon cancer metastasis.  \nDiscussion: This trial will determine the efficacy and safety of QSJDD and provide evidence regarding its role in theadjuvant treatment of colon cancer.  \nKeywords  \nQu-Shi-Jie-Du decoction, colon cancer, Chinese herbal medicine, protocol, randomized controlled trial Received: March 25, 2025; accepted: October 27, 2025  \nIntroduction  \nColorectal cancer (CRC) is one of the most common malignancies worldwide, with over 1.9 million new cases and approximately 900,000 deaths reported in 2022, accounting for nearly 10% of all cancer-related incidences and fatalities.1 In China, more than 60% of patients with primary colon cancer are diagnosed at stage II or III.2 For these patients, curative surgery followed by adjuvant chemotherapy remains the standard treatment approach. According to  \nthe National Comprehensive Cancer Network (NCCN) guidelines, 3 to 6 months of adjuvant chemotherapy is recommended for patients with high-risk stage II or stage III colon cancer, typically involving FOLFOX or CAPOX regimens.3,4 Recent follow-up data from the International Duration Evaluation of Adjuvant Therapy (IDEA) trial support a 3-month course of CAPOX as an effective adjuvant treatment for patients with high-risk stage II and most stage III colon cancer.5,6 However, despite standard adjuvant chemotherapy, up to 40% of high-risk stage III patients (T4 or  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons AttributionNonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) whi","cbCaim3M7khW6xLZ","https://ap.wps.com/l/cbCaim3M7khW6xLZ","pdf",2118307,14,"English","# Abstract\n## Background and Objective\n## Methods\n## Endpoints and Assessments\n## Discussion\n# Introduction","[{\"question\":\"What is the main purpose of this QSJDD clinical trial protocol?\",\"answer\":\"To evaluate the safety and efficacy of Qu-Shi-Jie-Du decoction in preventing colon cancer recurrence and liver metastasis in high-risk stage II or III patients.\"},{\"question\":\"How is the trial designed and what interventions will participants receive?\",\"answer\":\"This multicentre, double-blind, randomized, placebo-controlled trial assigns 336 patients to receive either QSJDD compound granules or placebo for 6 months after surgery and chemotherapy, followed for 3 years.\"},{\"question\":\"What outcomes will be used to judge effectiveness and safety?\",\"answer\":\"The primary endpoint is the 3-year disease-free survival rate, with secondary endpoints including 1- and 2-year disease-free survival, overall survival, and changes in the Traditional Chinese Medicine Dampness Syndrome Scale, while safety and adverse events will be tracked.\"}]","Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer - Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial | PDF",1790062148,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4b7eb2684ced771a69482be08810138.webp",983,1276,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bf3466c5ed8e4c8e6df7be4f7fbb74b.webp",982,1275,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37ef472958d4b9ec6c907d9f63155f44.webp",981,1273,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9176a39a4285ae5ca301c08d0f6178ae.webp",980,1272]